Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee

Affiliations

• ¹ National Abortion Federation, 1090 Vermont Ave NW Suite 1000, Washington DC, 20005, USA. Electronic address: [email protected].
• ² National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; University of Ottawa, Ottawa, Ontario, Canada. Electronic address: [email protected].
• ³ National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; University of California San Francisco and Advancing New Standards in Reproductive Health Care (ANSIRH), San Francisco, CA, USA. Electronic address: [email protected].
• ⁴ National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; University of Washington, Seattle, WA, USA. Electronic address: [email protected].
• ⁵ National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; Dupont Clinic, Washington DC, USA. Electronic address: [email protected].
• ⁶ National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; Fundación Oriéntame and ESAR, Bogotá, Colombia. Electronic address: [email protected].
• ⁷ National Abortion Federation, Clinical Policies Committee, Washington, DC, USA; Gynuity Health Projects, New York City, NY, USA. Electronic address: [email protected].